Free Trial
ASX:AVH

AVITA Medical (AVH) Stock Price, News & Analysis

AVITA Medical logo

About AVITA Medical Stock (ASX:AVH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
27.28 million shs
Average Volume
N/A
Market Capitalization
$226.55 million
P/E Ratio
N/A
Dividend Yield
0.30%
Price Target
N/A
Consensus Rating
N/A

Company Overview

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Receive AVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter.

AVH Stock News Headlines

Memorial Day Sale! 82% Off Disruptors and Dominators!
Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidia CEO walked on stage, you could've heard a pin drop. Why? Robots — built by Nvidia.
Investors overly negative on undervalued ASX share
ASX shares plunge but remain undervalued
See More Headlines

AVH Stock Analysis - Frequently Asked Questions

AVITA Medical, Inc. (ASX:AVH) announced its quarterly earnings data on Thursday, February, 28th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. AVITA Medical had a negative net margin of 77.47% and a negative trailing twelve-month return on equity of 39.79%.

Based on aggregate information from My MarketBeat watchlists, some other companies that AVITA Medical investors own include AVITA MED LTD/S (AVMXY), AVITA Medical (RCEL), Audentes Therapeutics (BOLD), Northern Dynasty Minerals (NAK), Orchid Island Capital (ORC), 88 Energy (88E) and Magellan Financial Group (MFG).

Company Calendar

Last Earnings
2/28/2019
Today
5/24/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
Electronic Equipment
Current Symbol
ASX:AVH
CIK
N/A
Fax
N/A
Employees
207
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-49,830,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$54.14 million
Price / Cash Flow
8.47
Book Value
A$1.00 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$226.55 million
Optionable
Not Optionable
Beta
1.54
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:AVH) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners